Saltar al contenido
Merck

Decreased Kv1.5 expression in intrauterine growth retardation rats with exaggerated pulmonary hypertension.

American journal of physiology. Lung cellular and molecular physiology (2013-10-01)
Ying Lv, Li-Li Tang, Jia-Kai Wei, Xue-Feng Xu, Weizhong Gu, Lin-Chen Fu, Li-Yan Zhang, Li-Zhong Du
RESUMEN

Chronic hypoxia pulmonary hypertension (CH-PHT) in adulthood is likely to be of fetal origin following intrauterine growth retardation (IUGR). Oxygen (O₂)-sensitive voltage-gated potassium channels (Kv channels) in resistance pulmonary artery smooth muscle cells (PASMCs) play an important role in scaling pulmonary artery (PA) pressure. Expression and functional changes of Kv channels are determined, in part, by embryonic development. We hypothesized that O₂-sensitive Kv channels play an important role in exaggerated CH-PHT following IUGR. We established a rat model of IUGR by restricting maternal food during the entire pregnancy and exposed IUGR rats and their age-matched controls aged 12 wk to hypoxia for 2 wk. We found that hypoxia exposure significantly induced increased PA pressure and thicker smooth muscle layer in the IUGR group relative to controls. We compared the constriction of the resistance PA to inhibitors of K⁺ channels, 4-aminopyridine (4-AP), tetraethylammonium, and BaCl₂. Despite the thickness of the smooth muscle layer, the constriction to 4-AP was significantly reduced in the IUGR group exposed to hypoxia. Consistent with these changes in pulmonary vascular reactivity, 2 wk of hypoxia induced weaker 4-AP-sensitive Kv currents in a single IUGR PASMC. Moreover, after 2 wk of hypoxia, Kv1.5 expression in resistance PAs decreased significantly in the IUGR group. Overexpression of Kv1.5 in cultured PASMCs could offset hypoxia-induced cell proliferation and hypoxia-inhibited Kv currents in the IUGR group. These results suggest that the inhibited expression of Kv1.5 in PASMCs contribute to the development of exaggerated CH-PHT in IUGR rats during adulthood.

MATERIALES
Número de producto
Marca
Descripción del producto

Roche
Reactivo de transfección de ADN X-tremeGENE HP, High-performance polymer reagent for transfecting many cell lines
Sigma-Aldrich
Barium chloride dihydrate, ACS reagent, ≥99%
Sigma-Aldrich
Barium chloride dihydrate, ≥99%
Sigma-Aldrich
Acetylcholine chloride, ≥99% (TLC)
Sigma-Aldrich
Barium chloride, 99.9% trace metals basis
Sigma-Aldrich
Tetraethylammonium chloride, ≥98% (titration)
Sigma-Aldrich
Tetraethylammonium hydroxide solution, 35 wt. % in H2O
Sigma-Aldrich
4-Aminopyridine, 98%
Sigma-Aldrich
Tetraethylammonium bromide, reagent grade, 98%
Sigma-Aldrich
4-Aminopyridine, ≥99%
Sigma-Aldrich
Barium chloride, 99.999% trace metals basis
Sigma-Aldrich
Acetylcholine chloride, suitable for cell culture
Sigma-Aldrich
Tetraethylammonium bromide, ReagentPlus®, 99%
Sigma-Aldrich
Monoclonal Anti-Green Fluorescent Protein (GFP) antibody produced in mouse, clone GFP-20, ascites fluid
Sigma-Aldrich
Tetraethylammonium hydroxide solution, 20 wt. % in H2O
Sigma-Aldrich
Acetylcholine iodide, ≥97%
Sigma-Aldrich
Barium chloride, AnhydroBeads, −10 mesh, 99.999% trace metals basis
Sigma-Aldrich
Acetylcholine chloride, pkg of 150 mg (per vial)
Sigma-Aldrich
Tetraethylammonium iodide, 98%
Sigma-Aldrich
Barium chloride dihydrate, ≥99.999% trace metals basis
Sigma-Aldrich
Tetraethylammonium hydroxide solution, ~25% in methanol (~1.5 M)
Sigma-Aldrich
Tetraethylammonium chloride, BioUltra, Molecular Biology, ≥99.0% (AT)
Sigma-Aldrich
Tetraethylammonium chloride hydrate
Sigma-Aldrich
Acetylcholine bromide, ≥99%
Sigma-Aldrich
Barium chloride, AnhydroBeads, −10 mesh, 99.95% trace metals basis
Supelco
Tetraethylammonium chloride, for electrochemical analysis, ≥99.0%
Supelco
Tetraethylammonium hydroxide solution, ~1.0 M (CH3CH2)4NOH in H2O, electrochemical grade
Sigma-Aldrich
Acetylcholine chloride, ≥99% (TLC), free-flowing, Redi-Dri
Sigma-Aldrich
Anti-KCNS3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution